355 related articles for article (PubMed ID: 16552236)
21. Targeted therapy in head and neck cancer: state of the art 2007 and review of clinical applications.
Langer CJ
Cancer; 2008 Jun; 112(12):2635-45. PubMed ID: 18442098
[TBL] [Abstract][Full Text] [Related]
22. EGFR antibody-supplemented TPE-chemotherapy. Preclinical investigations to a novel approach for head and neck cancer induction treatment.
Knecht R; Peters S; Solbach C; Baghi M; Gstöttner W; Hambek M
Anticancer Res; 2003; 23(6C):4789-95. PubMed ID: 14981927
[TBL] [Abstract][Full Text] [Related]
23. Drug Insight: cetuximab in the treatment of recurrent and metastatic squamous cell carcinoma of the head and neck.
Bernier J
Nat Clin Pract Oncol; 2008 Dec; 5(12):705-13. PubMed ID: 18825142
[TBL] [Abstract][Full Text] [Related]
24. Molecular-targeted therapy of head and neck squamous cell carcinoma: beyond cetuximab-based therapy.
Machiels JP; Schmitz S
Curr Opin Oncol; 2011 May; 23(3):241-8. PubMed ID: 21358328
[TBL] [Abstract][Full Text] [Related]
25. Head and neck cancer: integrating anti-EGFR treatment with standard therapy.
Kies MS
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S52-9. PubMed ID: 19780246
[TBL] [Abstract][Full Text] [Related]
26. Novel therapeutic approaches to squamous cell carcinoma of the head and neck using biologically targeted agents.
Harrington KJ; Kazi R; Bhide SA; Newbold K; Nutting CM
Indian J Cancer; 2010; 47(3):248-59. PubMed ID: 20587899
[TBL] [Abstract][Full Text] [Related]
27. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].
Tahara M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():167-71. PubMed ID: 16897996
[TBL] [Abstract][Full Text] [Related]
28. Targeted therapies and radiation for the treatment of head and neck cancer: are we making progress?
Raben D; Bianco C; Milas L; Ang KK
Semin Radiat Oncol; 2004 Apr; 14(2):139-52. PubMed ID: 15095260
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in the management of squamous cell carcinoma of the head and neck.
Kim KB; Khuri FR; Shin DM
Expert Rev Anticancer Ther; 2001 Jun; 1(1):99-110. PubMed ID: 12113140
[TBL] [Abstract][Full Text] [Related]
30. Targeted therapies in squamous cell carcinoma of the head and neck.
Gold KA; Lee HY; Kim ES
Cancer; 2009 Mar; 115(5):922-35. PubMed ID: 19156911
[TBL] [Abstract][Full Text] [Related]
31. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review.
Murdoch D
Curr Opin Oncol; 2007 May; 19(3):216-21. PubMed ID: 17414639
[TBL] [Abstract][Full Text] [Related]
32. New advances in targeted therapies for squamous cell carcinoma of the head and neck.
Machiels JP; Schmitz S
Anticancer Drugs; 2011 Aug; 22(7):626-33. PubMed ID: 21048493
[TBL] [Abstract][Full Text] [Related]
33. Acquired resistance to EGFR inhibitors: mechanisms and prevention strategies.
Viloria-Petit AM; Kerbel RS
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):914-26. PubMed ID: 14967451
[TBL] [Abstract][Full Text] [Related]
34. The role of targeted agents in preoperative chemoradiation for rectal cancer.
Wadlow RC; Ryan DP
Cancer; 2010 Aug; 116(15):3537-48. PubMed ID: 20564106
[TBL] [Abstract][Full Text] [Related]
35. Advances in the systemic treatment of head and neck cancers.
Specenier P; Vermorken JB
Curr Opin Oncol; 2010 May; 22(3):200-5. PubMed ID: 20154619
[TBL] [Abstract][Full Text] [Related]
36. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.
Gadducci A; Cosio S; Genazzani AR
Crit Rev Oncol Hematol; 2006 Jun; 58(3):242-56. PubMed ID: 16436330
[TBL] [Abstract][Full Text] [Related]
37. New perspectives in medical approach to therapy of head and neck squamous cell carcinoma.
Santarelli A; Lo Russo L; Bambini F; Campisi G; Lo Muzio L
Minerva Stomatol; 2009 Sep; 58(9):445-52. PubMed ID: 19893469
[TBL] [Abstract][Full Text] [Related]
38. Paradigm shift in the treatment of head and neck cancer: the role of neoadjuvant chemotherapy.
Posner MR
Oncologist; 2005; 10 Suppl 3():11-9. PubMed ID: 16368867
[TBL] [Abstract][Full Text] [Related]
39. [Role of targeted therapy in the treatment of squamous cell head and neck cancer].
Gyergyay F
Magy Onkol; 2007; 51(2):155-7. PubMed ID: 17660872
[TBL] [Abstract][Full Text] [Related]
40. Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Cohen EE
J Clin Oncol; 2006 Jun; 24(17):2659-65. PubMed ID: 16763280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
